Browsing by Subject
Ara mostrant els elements 1-14 d 14
-
Effect of Evobrutinib on Slowly Expanding Lesion Volume in Relapsing Multiple Sclerosis: A Post Hoc Analysis of a Phase 2 Trial
(Wolters Kluwer Health, 2024-03-12) -
Effect of Ozanimod on Symbol Digit Modalities Test Performance in Relapsing MS
(Elsevier, 2021-02) -
Immunomodulatory Effects Associated with Cladribine Treatment
(MDPI, 2021-12) -
Role of B Cell Profile for Predicting Secondary Autoimmunity in Patients Treated With Alemtuzumab
(Frontiers Media, 2021-10) -
Safety of Ocrelizumab in Patients With Relapsing and Primary Progressive Multiple Sclerosis
(Lippincott Williams & Wilkins, 2021-10-19)